Updated just now · Live
Stock analysis, price data, and AI-powered insights for Dexcom (DXCM).
Dexcom operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for DXCM.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). DXCM Stock Intelligence Report. [stoxpulse.com/stocks/dxcm]
Disclaimer: The information on this page about Dexcom (DXCM) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Dexcom.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Earnings Scheduled For April 30, 2026
7h ago
DXCM or MASI: Which Is the Better Value Stock Righ...
22h ago
StoxPulse AI results for DXCM: Pulse Score 59.5/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$22.21B
P/E Ratio
—
EPS
$0.70
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sector
Healthcare
Industry
Health Care Equipment
Earnings Scheduled For April 30, 2026
DXCM or MASI: Which Is the Better Value Stock Right Now?
DexCom (DXCM) Q1 Earnings: What To Expect
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
Is DexCom (DXCM) Now Fairly Priced After Recent Share Price Weakness?
The Ithaka Group 1Q26 Performance: Contributors And Detractors